Pembrolizumab Effects on NK Cell Exhaustion in Melanoma (Merck NK-IIT)
Clinical trial NCT03241927 · TERMINATED
Trial details
- NCT number
- NCT03241927
- Sponsor
- Nina Bhardwaj
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-20
- Primary completion
- 2018-06-06
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.